EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis, Biological Evaluation, Molecular Docking and Molecular Dynamics of Substituted Thieno[2,3-d]pyrimidine Derivatives as Potential Anti-Alzheimer Agents

Asma K Alshamari iD, Nourhan Magdy, Ebtesam A Basiony, Nasser A Hassan iD, Odeh A O Alshammari iD, Adel A-H Abdel-Rahman, Nuha O S Alsaif iD, Mona Z Alshammari, Ahmed A Elrashedy, Allam A Hassan iD

International Journal of Molecular Sciences · 08.07.2026 · 27 (14) · 6119

DOI: 10.3390/ijms27146119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2026. Verfasst von Asma K Alshamari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Science, Ha'il University, Ha'il 81451, Saudi Arabia. Hauptthemen laut MEDLINE: Pyrimidines, Cholinesterase Inhibitors, Molecular Docking Simulation, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ha'il.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thienopyrimidine derivatives are emerging as potent scaffolds for cholinesterase inhibition in Alzheimer’s disease therapy. In this work, a novel series of substituted thieno[2,3-d]pyrimidines was synthesized via Gewald’s reaction, followed by cyclization and functionalization through nucleophilic substitution and hydrazone formation. Structural confirmation was achieved using spectroscopic techniques, and biological evaluation was performed against acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), with donepezil and rivastigmine as reference drugs. Compound 4 emerged as the most potent and selective AChE inhibitor (IC50 = 0.58 µM), while compound 7 also showed strong AChE inhibition (IC50 = 0.63 µM). Notably, compound 9 exhibited superior BChE inhibition (IC50 = 3.05 µM) compared to donepezil (IC50 = 8.41 µM). Dual inhibitory activity was observed for compounds 5, 6, and 11, highlighting their multitarget potential. Molecular dynamics simulations (200 ns) and MM/GBSA binding free energy calculations provided mechanistic insights. Compound 4 showed the most favorable binding energy (ΔGbind = −59.16 kcal/mol), driven by hydrogen bonds with Tyr121 and Glu199 and π-π stacking with Trp83. Residue-level decomposition identified Tyr121, Trp83, Glu199, and Tyr338 as critical contributors to binding stability. Structure–activity relationship analysis confirmed that nitrogen-containing substituents and cyclic amino moieties enhance potency, whereas bulky aromatic groups reduce activity. These findings establish thieno[2,3-d]pyrimidine derivatives as promising candidates for the development of next-generation anti-Alzheimer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinesCholinesterase InhibitorsMolecular Docking SimulationAlzheimer DiseaseMolecular Dynamics SimulationAcetylcholinesteraseStructure-Activity RelationshipHumansButyrylcholinesterase

Stichwörter der Autor:innen

Alzheimer’s diseaseMM/GBSASAR analysisacetylcholinesterase inhibitionbutyrylcholinesterasedual inhibitorsmolecular dockingmolecular dynamicsthieno[2,3-d]pyrimidineβ-enaminonitriles

Substanzen

PyrimidinesCholinesterase InhibitorsAcetylcholinesteraseButyrylcholinesterasethieno(2,3-d)pyrimidine

Autor:innen und Institutionen

  • Department of Chemistry, College of Science, Ha'il University, Ha'il 81451, Saudi Arabia.
  • Department of Chemistry, Faculty of Science, Menofia University, Shbien El-Kom 32511, Egypt.
  • Department of Photochemistry, Synthetic Unit, Chemical Industries Research Institute, National Research Centre, 33 El Buhouth Street, Cairo P.O. Box 12622, Egypt.
  • Natural and Microbial Chemistry Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, 33 El Buhouth Street, Cairo P.O. Box 12622, Egypt.
  • College of Pharmacy, Al-Farahidi University, Baghdad 10021, Iraq.
  • Department of Chemistry, Faculty of Science, Suez University, Suez 43221, Egypt.

ORCID-Profile: Asma K Alshamari, Nasser A Hassan, Odeh A O Alshammari, Nuha O S Alsaif, Allam A Hassan

Förderung

  • University of Ha'il

Zitieren

APA

Alshamari, A. K., Magdy, N., Basiony, E. A., Hassan, N. A., Alshammari, O. A. O., Abdel-Rahman, A. A., Alsaif, N. O. S., Alshammari, M. Z., Elrashedy, A. A., & Hassan, A. A. (2026). Synthesis, Biological Evaluation, Molecular Docking and Molecular Dynamics of Substituted Thieno[2,3-d]pyrimidine Derivatives as Potential Anti-Alzheimer Agents. International Journal of Molecular Sciences, 27(14), 6119. https://doi.org/10.3390/ijms27146119

Vancouver

Alshamari AK, Magdy N, Basiony EA, Hassan NA, Alshammari OAO, Abdel-Rahman AA, et al. Synthesis, Biological Evaluation, Molecular Docking and Molecular Dynamics of Substituted Thieno[2,3-d]pyrimidine Derivatives as Potential Anti-Alzheimer Agents. International Journal of Molecular Sciences. 2026;27(14):6119. doi:10.3390/ijms27146119

BibTeX
@article{Alshamari2026,
  author = {Alshamari, Asma K and Magdy, Nourhan and Basiony, Ebtesam A and Hassan, Nasser A and Alshammari, Odeh A O and Abdel-Rahman, Adel A-H and Alsaif, Nuha O S and Alshammari, Mona Z and Elrashedy, Ahmed A and Hassan, Allam A},
  title = {Synthesis, Biological Evaluation, Molecular Docking and Molecular Dynamics of Substituted Thieno[2,3-d]pyrimidine Derivatives as Potential Anti-Alzheimer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {14},
  pages = {6119},
  doi = {10.3390/ijms27146119}
}
Kostenlos starten →